Human FAS/ALPS1A/APO-1 ORF/cDNA clone-Adenovirus plasmid (BC012479)

Cat. No.: pGMAP000450
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human FAS/ALPS1A/APO-1 adenoviral expression plasmid for FAS adenovirus packaging, FAS adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.


Target products collection

Go to Fas/CD95/FAS/FAS/ALPS1A products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAP000450
Gene Name FAS
Accession Number BC012479
Gene ID 355
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 1008 bp
Gene Alias ALPS1A,APO-1,CD95,FASTM
Fluorescent Reporter GFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGCTGGGCATCTGGACCCTCCTACCTCTGGTTCTTACGTCTGTTGCTAGATTATCGTCCAAAAGTGTTAATGCCCAAGTGACTGACATCAACTCCAAGGGATTGGAATTGAGGAAGACTGTTACTACAGTTGAGACTCAGAACTTGGAAGGCCTGCATCATGATGGCCAATTCTGCCATAAGCCCTGTCCTCCAGGTGAAAGGAAAGCTAGGGACTGCACAGTCAATGGGGATGAACCAGACTGCGTGCCCTGCCAAGAAGGGAAGGAGTACACAGACAAAGCCCATTTTTCTTCCAAATGCAGAAGATGTAGATTGTGTGATGAAGGACATGGCTTAGAAGTGGAAATAAACTGCACCCGGACCCAGAATACCAAGTGCAGATGTAAACCAAACTTTTTTTGTAACTCTACTGTATGTGAACACTGTGACCCTTGCACCAAATGTGAACATGGAATCATCAAGGAATGCACACTCACCAGCAACACCAAGTGCAAAGAGGAAGGATCCAGATCTAACTTGGGGTGGCTTTGTCTTCTTCTTTTGCCAATTCCACTAATTGTTTGGGTGAAGAGAAAGGAAGTACAGAAAACATGCAGAAAGCACAGAAAGGAAAACCAAGGTTCTCATGAATCTCCAACCTTAAATCCTGAAACAGTGGCAATAAATTTATCTGATGTTGACTTGAGTAAATATATCACCACTATTGCTGGAGTCATGACACTAAGTCAAGTTAAAGGCTTTGTTCGAAAGAATGGTGTCAATGAAGCCAAAATAGATGAGATCAAGAATGACAATGTCCAAGACACAGCAGAACAGAAAGTTCAACTGCTTCGTAATTGGCATCAACTTCATGGAAAGAAAGAAGCGTATGACACATTGATTAAAGATCTCAAAAAAGCCAATCTTTGTACTCTTGCAGAGAAAATTCAGACTATCATCCTCAAGGACATTACTAGTGACTCAGAAAATTCAAACTTCAGAAATGAAATCCAAAGCTTGGTCTAG
ORF Protein Sequence MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T14592-Ab Anti-TNR6/ FAS/ ALPS1A monoclonal antibody
    Target Antigen GM-Tg-g-T14592-Ag FAS VLP (virus-like particle)
    ORF Viral Vector pGMAP000450 Human FAS Adenovirus plasmid
    ORF Viral Vector vGMAP000450 Human FAS Adenovirus particle


    Target information

    Target ID GM-T14592
    Target Name Fas/CD95/FAS
    Gene Group Identifier
    (Target Gene ID in Homo species)
    355
    Gene ID 100071639 (Equus caballus), 14102 (Mus musculus), 246097 (Rattus norvegicus), 282488 (Bos taurus)
    355 (Homo sapiens), 486469 (Canis lupus familiaris), 493881 (Felis catus), 574332 (Macaca mulatta)
    Gene Symbols & Synonyms FAS,Fas,lpr,APO1,APT1,CD95,TNFR6,Tnfrsf6,FasR,TNFRSF6,FAS1,APO-1,FASTM,ALPS1A
    Target Alternative Names Fas, CD95, FAS,Tumor necrosis factor receptor superfamily member 6,Apo-1 antigen, Apoptosis-mediating surface antigen FAS, FASLG receptor,APT1,CD95,FAS1,APO-1,FASTM,ALPS1A,TNFRSF6
    Uniprot Accession P25445,P25446,P51867,Q63199,Q9BDP2
    Additional SwissProt Accessions: P25446,Q63199,P51867,P25445,Q9BDP2
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target
    Disease cancer, Chronic Kidney Disease, Urinary bladder urothelial carcinoma, ovarian cancer
    Disease from KEGG MAPK signaling pathway, Cytokine-cytokine receptor interaction, p53 signaling pathway, Apoptosis, Natural killer cell mediated cytotoxicity, TNF signaling pathway, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Pathogenic Escherichia coli infection, Chagas disease, African trypanosomiasis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Epstein-Barr virus infection, Pathways in cancer, Proteoglycans in cancer, Autoimmune thyroid disease, Allograft rejection, Graft-versus-host disease, Lipid and atherosclerosis
    Gene Ensembl ENSECAG00000013724, ENSMUSG00000024778, ENSBTAG00000010785, ENSG00000026103, ENSCAFG00845029855, ENSMMUG00000009339
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.